Update: My blog posting has an updated results table here.
Metastatic pancreatic adenocarcinoma patients (PDAC) don't have a lot of good options. Here, I summarize the completed phase III trials for metastatic patients, outlining the basic survival statistics. The trial name is a link to the full-text trial results, except the NAPOLI-1 trial that hasn't fully published yet.
The blog hosting software for this site is limiting me to 10K characters, so I am posting a full
Updated Yesterday at 04:33 PM by ddessert
It can be hard to find information about drugs we might want to use and how they performed in clinical trials. Google Scholar is one of my first lines of search.
I've found that adding the search string:
median "95% CI"
(including the double-quotes around 95% CI) to my drug queries help limit the returned hits to useful papers. So, a search for papers containing results using the drug Abraxane might be:
Abraxane "clinical trial" median
Updated 06-02-2015 at 04:58 PM by ddessert
For nutrition, I suggest a GI oncology nutritionist at one of the major hospitals. This is a nutritionist who is familiar with blocked bile ducts, blocked pancreatic ducts, an impaired pancreas and other metastatic organs, nausea, low blood counts, low iron levels, etc. The gastrointestinal cancer patient is not functioning at 100%. In addition, several organs aren't even present (you probably have no idea how critical the duodenum can be). You need a specialist that recognizes that fact and can